Following reports of adverse events possibly related to Tamiflu, the Japanese Health Ministry said it will release information about the safety of prescription drugs. Starting in January, the Pharmaceuticals and Medical Devices Agency will publish detailed data on all of the reports it receives on adverse events caused by prescription drugs and medical devices on a Web site. The agency already publishes limited data on some events. Assuming the plan goes forward, the reporting initiative would be the among most comprehensive adopted by any government.
- see this article from the Ashai Shimbun